Sep 25, 2025 • Zacks Commentary
SOMEWHAT-BULLISH
Zacks Industry Outlook Highlights Quest Diagnostics, DaVita, Addus HomeCare and The Pennant
Quest Diagnostics, DaVita, Addus HomeCare, and The Pennant Group are positioned to benefit from telehealth, AI adoption, and rising demand in the $747B home healthcare market.
Sep 25, 2025 • Zacks Commentary
NEUTRAL
Is the Options Market Predicting a Spike in Addus HomeCare Stock?
Investors need to pay close attention to ADUS stock based on the movements in the options market lately.
Sep 24, 2025 • Zacks Commentary
SOMEWHAT-BULLISH
4 Outpatient Home Health Stocks Worth Watching Amid Shifting Trends
An aging global population and AI dominance are likely to drive the Zacks Medical - Outpatient and Home Healthcare industry despite the macroeconomic challenges. DGX, DVA, ADUS and PNTG are well-poised to gain.
Aug 27, 2025 • Benzinga
SOMEWHAT-BULLISH
Sell Alert: Brian Poff Cashes Out $904K In Addus HomeCare Stock - Addus HomeCare ( NASDAQ:ADUS )
A substantial insider sell was reported on August 26, by Brian Poff, EVP at Addus HomeCare ADUS, based on the recent SEC filing. What Happened: Poff's decision to sell 7,739 shares of Addus HomeCare was revealed in a Form 4 filing with the U.S. Securities and Exchange Commission on Tuesday.
Aug 22, 2025 • Benzinga
SOMEWHAT-BULLISH
Insider Move: R. Dirk Allison Exercises Options, Realizing $2.36M At Addus HomeCare - Addus HomeCare ( NASDAQ:ADUS )
On August 21, it was revealed in an SEC filing that R. Dirk Allison, Chairman and CEO at Addus HomeCare ADUS executed a significant exercise of company stock options.
Aug 05, 2025 • Motley Fool
BULLISH
Addus HomeCare ( ADUS ) Q2 Revenue Up 22%
Addus HomeCare ( NASDAQ:ADUS ) , a leading provider of home-based personal care, hospice, and home health services, reported its second quarter 2025 financial results on August 4, 2025. The company posted revenue ( GAAP ) and earnings per share ( non-GAAP ) figures that exceeded Wall Street ...